Spine BioPharma develops a non-surgical solution for back pain that eliminates pain and restores functionality.
Spine BioPharma has raised $13.5M in total funding. The most recent round was Undisclosed. The last funding was announced in December 2024.
Spine BioPharma's investors include Pacira Pharmaceuticals, Viscogliosi Brothers, Vulcan Capital, Cercano Management.
Spine BioPharma is headquartered in New York, United States.
Spine BioPharma develops a non-surgical solution for back pain that eliminates pain and restores functionality.
Spine BioPharma is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Spine BioPharma — Funding & Investors." VCBacked, December 18, 2024, https://www.vcbacked.co/company/spine-biopharma. Accessed October 9, 2026.
VCBacked. (2024). Spine BioPharma — Funding & Investors. Retrieved October 9, 2026, from https://www.vcbacked.co/company/spine-biopharma
{{cite web |title=Spine BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/spine-biopharma |website=VCBacked |access-date=October 9, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated